BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Z, Jia J, Heng G, Xu H, Shan J, Wang G, Liu C, Xia J, Zhou H, Wu M, Yang Z, Wang M, Xiong Z, Huang H, Liu L, Qian C. Sirtuin-1/Mitochondrial Ribosomal Protein S5 Axis Enhances the Metabolic Flexibility of Liver Cancer Stem Cells. Hepatology 2019;70:1197-213. [PMID: 30901096 DOI: 10.1002/hep.30622] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu AR, Lv Z, Yan ZW, Wu XY, Yan LR, Sun LP, Yuan Y, Xu Q. Association of mitochondrial homeostasis and dynamic balance with malignant biological behaviors of gastrointestinal cancer. J Transl Med 2023;21:27. [PMID: 36647167 DOI: 10.1186/s12967-023-03878-1] [Reference Citation Analysis]
2 Xie C, Hu J, Hu Q, Jiang L, Chen W. Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma. Front Surg 2022;9:1062659. [PMID: 36684217 DOI: 10.3389/fsurg.2022.1062659] [Reference Citation Analysis]
3 Zhu W, Zhang X, Yu M, Zhang Y, Li S, Yu C, Muhammad N. Profiles of Acetylation Regulation Genes Contribute to Malignant Progression and Have a Clinical Prognostic Impact on Liver Cancer. Disease Markers 2022;2022:1-19. [DOI: 10.1155/2022/1724301] [Reference Citation Analysis]
4 Xu Q, Liu X, Mohseni G, Hao X, Ren Y, Xu Y, Gao H, Wang Q, Wang Y. Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment. Cancer Cell Int 2022;22:242. [PMID: 35906622 DOI: 10.1186/s12935-022-02664-1] [Reference Citation Analysis]
5 Xia H, Huang Z, Wang Z, Liu S, Zhao X, You J, Xu Y, Yam JWP, Cui Y. Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma. Front Oncol 2022;12:953668. [DOI: 10.3389/fonc.2022.953668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Man KF, Ma S. Mechanisms of resistance to tyrosine kinase inhibitors in liver cancer stem cells and potential therapeutic approaches. Essays Biochem 2022:EBC20220001. [PMID: 35818992 DOI: 10.1042/EBC20220001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bao S, Wang X, Li M, Gao Z, Zheng D, Shen D, Liu L. Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results. Front Oncol 2022;12:835549. [PMID: 35719986 DOI: 10.3389/fonc.2022.835549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Song BS, Moon JS, Tian J, Lee HY, Sim BC, Kim SH, Kang SG, Kim JT, Nga HT, Benfeitas R, Kim Y, Park S, Wolfe RR, Eun HS, Shong M, Lee S, Kim IY, Yi HS. Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion. J Immunother Cancer 2022;10:e004337. [PMID: 35580931 DOI: 10.1136/jitc-2021-004337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liang N, Yang T, Huang Q, Yu P, Liu C, Chen L, Wang Q, Wang G, He X. Mechanism of cancer stemness maintenance in human liver cancer. Cell Death Dis 2022;13:394. [PMID: 35449193 DOI: 10.1038/s41419-022-04848-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yao JY, Xu S, Sun YN, Xu Y, Guo QL, Wei LB. Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. Acta Pharmacol Sin 2022;43:1033-45. [PMID: 34188177 DOI: 10.1038/s41401-021-00708-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
11 Xia Y, Yang J, Li C, Hao X, Fan H, Zhao Y, Tang J, Wan X, Lian S, Yang J. TMT-Based Quantitative Proteomics Analysis Reveals the Panoramic Pharmacological Molecular Mechanism of β-Elemonic Acid Inhibition of Colorectal Cancer. Front Pharmacol 2022;13:830328. [PMID: 35242040 DOI: 10.3389/fphar.2022.830328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol 2022;19:26-44. [PMID: 34504325 DOI: 10.1038/s41575-021-00508-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 63.0] [Reference Citation Analysis]
13 David JC, Afonso MB, Rodrigues CMP. Metabolic Alterations of Hepatocellular Cancer Stem Cells. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_43] [Reference Citation Analysis]
14 Watroba M, Szukiewicz D. Sirtuins at the Service of Healthy Longevity. Front Physiol 2021;12:724506. [PMID: 34899370 DOI: 10.3389/fphys.2021.724506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Pandit SK, Sandrini G, Merulla J, Nobili V, Wang X, Zangari A, Rinaldi A, Shinde D, Carbone GM, Catapano CV. Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma. Cancers (Basel) 2021;13:6029. [PMID: 34885140 DOI: 10.3390/cancers13236029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhuo J, Lu D, Lin Z, Yang X, Yang M, Wang J, Tao Y, Wen X, Li H, Lian Z, Cen B, Dong S, Wei X, Xie H, Zheng S, Shen Y, Xu X. The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death Dis 2021;12:1084. [PMID: 34785656 DOI: 10.1038/s41419-021-04320-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Min S, Lee YK, Hong J, Park TJ, Woo HG, Kwon SM, Yoon G. MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness. Cell Death Dis 2021;12:1076. [PMID: 34772924 DOI: 10.1038/s41419-021-04370-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Qi F, Qin W, Zhang Y, Luo Y, Niu B, An Q, Yang B, Shi K, Yu Z, Chen J, Cao X, Xia J. Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. J Exp Clin Cancer Res 2021;40:280. [PMID: 34479623 DOI: 10.1186/s13046-021-02085-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sun CC, Zhao S, Chu LL, Zhang SY, Li YL, Sun MF, Wang QN, Huang Y, Zhang J, Wang H, Gao L, Xu DX, Zhang SC, Xu T, Zhao LL. Di (2-ethyl-hexyl) phthalate disrupts placental growth in a dual blocking mode. J Hazard Mater 2021;421:126815. [PMID: 34396966 DOI: 10.1016/j.jhazmat.2021.126815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
20 Lee HY, Nga HT, Tian J, Yi HS. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma. Cells 2021;10:1901. [PMID: 34440674 DOI: 10.3390/cells10081901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
21 Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj 2021;1865:129952. [PMID: 34147543 DOI: 10.1016/j.bbagen.2021.129952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
22 Mack N, Mazzio E, Badisa R, Soliman KFA. Metabolic Response to the Mitochondrial Toxin 1-Methyl-4-phenylpyridinium (MPP+) in LDH-A/B Double-knockout LS174T Colon Cancer Cells. Cancer Genomics Proteomics 2021;18:385-405. [PMID: 33994363 DOI: 10.21873/cgp.20267] [Reference Citation Analysis]
23 Chan LK, Tsui YM, Ho DW, Ng IO. Cellular heterogeneity and plasticity in liver cancer. Semin Cancer Biol 2021:S1044-579X(21)00050-X. [PMID: 33647386 DOI: 10.1016/j.semcancer.2021.02.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
24 Liu L, Borlak J. Advances in Liver Cancer Stem Cell Isolation and their Characterization. Stem Cell Rev Rep. 2021;epub ahead of print. [PMID: 33432485 DOI: 10.1007/s12015-020-10114-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
25 Patel MS, Mahmood S, Jung J, Rideout TC. Reprogramming of aerobic glycolysis in non-transformed mouse liver with pyruvate dehydrogenase complex deficiency. Physiol Rep 2021;9:e14684. [PMID: 33400855 DOI: 10.14814/phy2.14684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Morris BJ. Sirtuins and aging. Sirtuin Biology in Medicine 2021. [DOI: 10.1016/b978-0-12-814118-2.00017-3] [Reference Citation Analysis]
27 Fang Y, Li X. Sirtuins in metabolic and epigenetic regulation of stem cells. Sirtuin Biology in Cancer and Metabolic Disease 2021. [DOI: 10.1016/b978-0-12-822467-0.00004-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Ezhilarasan D, Najimi M. Role of sirtuins in liver diseases. Sirtuin Biology in Medicine 2021. [DOI: 10.1016/b978-0-12-814118-2.00005-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Xing Y, He J, Wen Y, Liu J, You Y, Weng X, Yuan L, Xiong L, Chen X, Zhang Y, Li HY. Polymorphisms in mitochondrial ribosomal protein S5 (MRPS5) are associated with leprosy risk in Chinese. PLoS Negl Trop Dis 2020;14:e0008883. [PMID: 33362202 DOI: 10.1371/journal.pntd.0008883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Aventaggiato M, Vernucci E, Barreca F, Russo MA, Tafani M. Sirtuins' control of autophagy and mitophagy in cancer. Pharmacol Ther 2021;221:107748. [PMID: 33245993 DOI: 10.1016/j.pharmthera.2020.107748] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
31 Zhang X, Guo J, Jabbarzadeh Kaboli P, Zhao Q, Xiang S, Shen J, Zhao Y, Du F, Wu X, Li M, Ji H, Yang X, Xiao Z, Wen Q. Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells. Onco Targets Ther 2020;13:7295-304. [PMID: 32801756 DOI: 10.2147/OTT.S257944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
32 Miao Y, Li Q, Sun G, Wang L, Zhang D, Xu H, Xu Z. MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer. Cancer Med 2020;9:7231-43. [PMID: 32780563 DOI: 10.1002/cam4.3344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
33 Du F, Li Z, Zhang G, Shaoyan S, Geng D, Tao Z, Qiu K, Liu S, Zhou Y, Zhang Y, Gu J, Wang G, Li L, Wu W. SIRT2, a direct target of miR-212-5p, suppresses the proliferation and metastasis of colorectal cancer cells. J Cell Mol Med 2020;24:9985-98. [PMID: 32697380 DOI: 10.1111/jcmm.15603] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
34 Zhou Z, Ma D, Li P, Wang P, Liu P, Wei D, Wang J, Qin Z, Fang Q, Wang J. Sirt1 gene confers Adriamycin resistance in DLBCL via activating the PCG-1α mitochondrial metabolic pathway. Aging (Albany NY) 2020;12:11364-85. [PMID: 32570218 DOI: 10.18632/aging.103174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Kwon SM, Lee YK, Min S, Woo HG, Wang HJ, Yoon G. Mitoribosome Defect in Hepatocellular Carcinoma Promotes an Aggressive Phenotype with Suppressed Immune Reaction. iScience 2020;23:101247. [PMID: 32629612 DOI: 10.1016/j.isci.2020.101247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Xia S, Pan Y, Liang Y, Xu J, Cai X. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine 2020;51:102610. [PMID: 31918403 DOI: 10.1016/j.ebiom.2019.102610] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 24.0] [Reference Citation Analysis]
37 Wang C, Jiang X, Li X, Song S, Meng Q, Wang L, Lu Y, Xin X, Pu H, Gui X, Li T, Lu D. Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy. Stem Cell Res Ther 2020;11:8. [PMID: 31900225 DOI: 10.1186/s13287-019-1528-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
38 Ren MT, Gu ML, Zhou XX, Yu MS, Pan HH, Ji F, Ding CY. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis. World J Gastroenterol 2019; 25(38): 5800-5813 [PMID: 31636473 DOI: 10.3748/wjg.v25.i38.5800] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
39 Farcas M, Gavrea AA, Gulei D, Ionescu C, Irimie A, Catana CS, Berindan-Neagoe I. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Front Nutr 2019;6:148. [PMID: 31608282 DOI: 10.3389/fnut.2019.00148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]